Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
BEFREE |
The experimental MGN rat models induced by cationic bovine serum albumin were established by a modified Border's method and applied in the pharmacodynamics study of ME BSA NPs.
|
29725902 |
2018 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
BEFREE |
Several other rare antigens have been described, including antibodies against neutral endopeptidase as a cause of antenatal MN and circulating cationic bovine serum albumin as an antigen with implications in childhood MN.
|
28904948 |
2017 |
Membranous glomerulonephritis
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Among DM patients without DR, patients with membranous nephropathy had significantly lower levels of serum albumin and serum creatinine, and significantly higher levels of high-density lipoprotein and cholesterol than those with DN.In conclusion, DN patients without DR may have less serious renal damage and less diabetic complication than those with DR.
|
28471980 |
2017 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
BEFREE |
It is remarkable that experimental models such as Heymann nephritis and cationic bovine serum albumin-induced MN in the rabbit predicted the pathomechanisms of the human glomerulopathy.
|
28597189 |
2017 |
Membranous glomerulonephritis
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Significant renal dysfunction was observed in MGN rats; comparatively, 4-week CM administration strongly decreased the levels of 24 h urine protein, total cholesterol, triglyceride, blood urea nitrogen and serum creatinine, and increased the levels of serum albumin and total serum protein.
|
27008597 |
2016 |
Membranous glomerulonephritis
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Kidney function was assessed by proteinuria for 24 hours, serum albumin, blood urea nitrogen (BUN), serum creatine, serum cystatin C. We assessed the correlation between anti-PLA2R antibody levels and clinical parameter in the PMN patients.
|
27179439 |
2016 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
BEFREE |
These studies led to the identification of neutral endopeptidase, the type-M phospholipase A2 receptor (PLA2R), and cationic bovine serum albumin as target antigens of circulating and deposited antibodies in neonatal alloimmune, adult 'idiopathic', and early childhood MN, respectively.
|
25401774 |
2014 |
Membranous glomerulonephritis
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Heparanase activity, albumin, HS and creatinine were measured in the urine of patients with T1D (n=58) or T2D (n=31), in patients with MGP (n=52) and in healthy controls (n=10).
|
22187315 |
2012 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
BEFREE |
Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy.
|
17622271 |
2007 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy.
|
17622271 |
2007 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences.
|
15385633 |
2004 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
[Mechanical research on effects of yishenqing on membranous nephropathy].
|
12776520 |
2002 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
[Experimental study on treatment of chronic renal failure with yishen qudu capsule].
|
11938814 |
2000 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
Effects of FK506 on experimental membranous glomerulonephritis induced by cationized bovine serum albumin in rats.
|
9794552 |
1998 |
Membranous glomerulonephritis
|
0.390 |
Biomarker
|
disease |
CTD_human |
Mesangial overload in experimental membranous nephropathy.
|
1342223 |
1992 |